Oncology Institute Inc. (TOI)
0.43
0.06 (16.25%)
At close: Jan 15, 2025, 12:02 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -83.07M | 1.66M | -10.93M | -14.32M | -4.02M | 3.95M |
| Depreciation & Amortization | 5.87M | 4.41M | 3.34M | 3.18M | 2.94M | 1.10M |
| Stock-Based Compensation | 17.81M | 27.68M | 24.54M | 151.00K | 94.01K | n/a |
| Other Working Capital | 6.18M | 7.71M | -13.37M | 4.46M | 3.38M | -4.49M |
| Other Non-Cash Items | 20.79M | -75.19M | -33.90M | 11.85M | 326.93K | 6.86M |
| Deferred Income Tax | -76.00K | 183.00K | -1.24M | -1.34M | 824.76K | 688.76K |
| Change in Working Capital | 2.36M | -20.50M | -14.49M | 991.92K | 3.45M | -97.58K |
| Operating Cash Flow | -36.31M | -61.76M | -32.68M | 508.24K | 3.62M | 5.64M |
| Capital Expenditures | -4.57M | -5.53M | -3.05M | -1.19M | -1.20M | -695.96K |
| Acquisitions | -4.46M | -8.58M | -9.11M | -150.00K | n/a | 3.18M |
| Purchase of Investments | -9.60M | -117.51M | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 81.26M | 126.08M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -126.08M | -200.00K | -7.50M | n/a | n/a |
| Investing Cash Flow | 62.64M | -131.61M | -12.15M | -8.84M | -1.20M | 2.49M |
| Debt Repayment | -101.00K | 109.94M | -7.25M | 12.18M | -1.81K | n/a |
| Common Stock Repurchased | -1.02M | -9.00M | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | -8.20M |
| Other Financial Acitivies | -5.73M | -8.74M | 161.26M | -293.00K | n/a | n/a |
| Financial Cash Flow | -6.85M | 92.21M | 154.01M | 11.89M | -1.81K | -8.20M |
| Net Cash Flow | 19.48M | -101.16M | 109.18M | 3.55M | 2.41M | -14.69K |
| Free Cash Flow | -40.88M | -67.28M | -35.73M | -685.88K | 2.41M | 4.95M |